EPA and DHA Market is Increase With a Healthy CAGR of 6.2% By 2023-2030
EPA and DHA Market Overview:
The EPA and DHA Market (Opens in a new window) was valued at USD 1,670.04 Million in 2022. EPA and DHA market estimated to reach over USD 2,680.43 Million by 2030.and grow at a CAGR of 6.2% during the forecast period.
Growth drivers: Rising awareness of health benefits, increasing prevalence of chronic diseases, growing demand for preventive healthcare, and expanding applications in food, dietary supplements, and clinical nutrition.
Key regions: North America, Europe, and Asia Pacific are leading the market, with Asia Pacific expected to witness the fastest growth due to rising disposable incomes and growing health awareness.
Market Drivers:
Health benefits: EPA and DHA are associated with reducing the risk of cardiovascular diseases, cognitive decline, and inflammatory conditions.
Chronic disease prevalence: Rising cases of heart disease, diabetes, and other chronic conditions are driving EPA and DHA market demand for preventive measures, including EPA and DHA supplementation.
Preventive healthcare: Growing focus on proactive health management is increasing the adoption of EPA and DHA for overall well-being.
Expanding applications: The use of EPA and DHA is expanding beyond dietary supplements to include functional foods, infant formula, pet food, and pharmaceuticals.
Market Key Players:
KD Pharma Group, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Polaris SA, and AlgalR NutraPharms Pvt. Ltd
Market Segmentation:
The Veterinary Diagnostic Imaging Market segmentation based on various factors, including:
By Type: Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA)
By Source: Fish Oil, Algae Oil, Krill Oil, and Others
By Application: Infant Formula, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, and Others
Regional Analysis
North America: A Mature Market with Steady Growth
Dominant force: The North American region currently holds the largest EPA and DHA Market Size (Opens in a new window), driven by factors like high disposable income, growing health awareness, and established distribution channels.
Focus on preventive healthcare: Consumers are increasingly opting for EPA and DHA supplements as part of their preventive healthcare regimens, particularly for heart and brain health.
Key players: The market is dominated by established players like BASF, DSM, and Amway, alongside regional players like Cargill and Omega Nutrition.
Europe: Stringent Regulations and Rising Demand
Regulatory landscape: Stringent regulations governing food and dietary supplements in Europe present both challenges and opportunities for market players.
Growing demand for fortified foods: Consumers are increasingly seeking fortified food products enriched with EPA and DHA, particularly for infant formula and functional foods.
Key players: Leading players include BASF, DSM, and Lonza, with regional players like Aker BioMarine and Orkla Health also gaining traction.
Asia Pacific: A Booming Market with Diverse Drivers
Rapid economic growth: Rising disposable incomes and increasing awareness of health benefits are fueling market expansion in this region.
Focus on infant nutrition and brain development: The demand for EPA and DHA-fortified infant formula is surging, driven by concerns about child development.
Key players: International players like BASF and DSM are present alongside regional players like China Resources and BYD Pharma.
Contact us:
Consegic Business intelligence Pvt Ltd. (Opens in a new window)
Contact no: (US) (505) 715-4344
Email: sales@consegicbusinessintelligence.com (Opens in a new window)
